Inventiva (IVA) Other Accumulated Expenses (2019 - 2025)

Inventiva (IVA) recorded quarterly Other Accumulated Expenses of $17.2 billion in Q2 2025, up 86.86% quarter-over-quarter from $9.2 billion in Q4 2024, and up 273225.25% on a YoY basis from N/an in Q2 2024.

Inventiva (IVA) Other Accumulated Expenses (2019 - 2025) Analysis & Trends

Inventiva's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $17.2 billion for Q2 2025.

  • In Q2 2025, Other Accumulated Expenses rose 273225.25% year-over-year to $17.2 billion; the TTM figure through Jun 2025 stood at $17.2 billion (up 273225.25% YoY), while the FY2024 annual figure was $9.2 billion, up 119108.59% from the prior year.
  • Other Accumulated Expenses was $17.2 billion for Q2 2025 at Inventiva, up from $9.2 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $17.2 billion in Q2 2025 to a low of $5.4 million in Q2 2023.
  • Historically, Other Accumulated Expenses has averaged $3.9 billion across 5 years, with a median of $8.2 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses tumbled 99.93% in 2022, then soared 273225.25% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $7.8 billion in 2021, then sank by 99.93% to $5.6 million in 2022, then jumped by 37.76% to $7.7 million in 2023, then soared by 119108.59% to $9.2 billion in 2024, then surged by 86.86% to $17.2 billion in 2025.
  • The last three Other Accumulated Expenses figures came in at $17.2 billion (Q2 2025), $9.2 billion (Q4 2024), and $6.3 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 Inventiva 8.93 Mn -259.80 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 17.17 Bn
Dec 31, 2024 9.19 Bn
Jun 30, 2024 6.28 Mn
Dec 31, 2023 7.71 Mn
Jun 30, 2023 5.42 Mn
Dec 31, 2022 5.60 Mn
Jun 30, 2022 5.01 Bn
Dec 31, 2021 7.77 Bn
Jun 30, 2021 5.43 Mn
Mar 31, 2021 8.71 Mn
Dec 31, 2020 8.15 Mn
Jun 30, 2020 5.88 Mn
Dec 31, 2019 5.53 Mn